Oligonucleotide, method and kit for detecting ETV6-RUNX1 fusion gene in sample
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- FUZHOU ADICON CLINICAL LAB INC
- Publication Date
- 2021-03-02
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of life science and biotechnology, and is specially designed to provide oligonucleotides, methods and kits for detecting ETV6-RUNX1 fusion genes in samples, and uses probe real-time fluorescent PCR technology to detect ETV6-RUNX1 in human B-ALL. RUNX1 fusion gene was detected. Background technique
[0002] The occurrence of leukemia is a complex and multi-step process. Chromosomal mutations can form fusion genes with tumor characteristics, and can also cause uncontrolled expression of some genes that play an important role in the regulation of cell growth and apoptosis, thereby interfering with cell proliferation and differentiation. The normal regulation pathway of , maturation and apoptosis, ultimately leading to leukemogenesis. Leukemia is the most common malignant tumor disease in childhood, with an incidence rate of 3-5 / 100,000, and it is also a disease that seriously threatens children's health. Acute lymphobl...